Advertisement
RayBiotech
RayBiotech

The Scientist

» pharma

Most Recent

image: @Pharma Branching Out

@Pharma Branching Out

By | June 11, 2012

More than half of pharmaceutical companies on Twitter use more than one handle.

0 Comments

image: Avant-Garde Science

Avant-Garde Science

By | June 1, 2012

Why naked mole-rats and experimental gene therapies remind me of groundbreaking artists.

0 Comments

image: Pharma Puts Up Money for Biotech

Pharma Puts Up Money for Biotech

By | March 21, 2012

GlaxoSmithKline and Johnson & Johnson contribute a total of $100 million to early-stage biotech endeavors.

0 Comments

image: Self-prescribing Patients?

Self-prescribing Patients?

By | March 13, 2012

The FDA considers making some drugs for diabetes, asthma, and other ailments available over the counter.

4 Comments

image: Opinion: A Big Pharma Biotech Fund

Opinion: A Big Pharma Biotech Fund

By | March 5, 2012

Pharmaceutical companies should deploy cash to fund struggling biotech companies, which could generate much needed new drugs.

4 Comments

image: Female Frontrunners

Female Frontrunners

By | February 1, 2012

How to successfully surmount the challenges women face in becoming biotech industry leaders

7 Comments

image: Opinion: Celebrities Pushing Drugs?

Opinion: Celebrities Pushing Drugs?

By | January 30, 2012

Celebrity spokespeople for pharma companies can manipulate the public’s understanding of disease.

30 Comments

image: FDA Drafts Pharma Social Media Advice

FDA Drafts Pharma Social Media Advice

By | January 3, 2012

The agency releases draft guidelines on unsolicited questions about off-label use, but leaves many questions about social media marketing unanswered.

0 Comments

image: The Companies that Failed

The Companies that Failed

By | December 20, 2011

A roundup of eight biotech companies that didn’t make it through this year's continuing tough economic times

6 Comments

image: Universities Roll-back Pharma’s Fees

Universities Roll-back Pharma’s Fees

By | December 20, 2011

Research universities are removing the licensing fees they charged industry companies for working with their scientists.

15 Comments

Advertisement

Popular Now

  1. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

  2. Most Earth-like Planet Found
  3. Ancient Viruses as Gene Therapy Vectors
  4. Judge Decides on GM Rice Retraction
Advertisement
PDA
PDA
Advertisement
Life Technologies